Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
J. Kremer,Zhan-Guo Li,11 Authors,John D. Bradley
2013 · DOI: 10.7326/0003-4819-159-4-201308200-00006
Annals of Internal Medicine · 309 Citations
TLDR
Tofacitinib improved disease control in patients with active RA despite treatment with nonbiologic DMARDs, primarily methotrexate.